| Literature DB >> 26074330 |
Xin Mao1, Zhengzheng Liao1, Lin Guo1, Xuan Xu1, Bo Wu1, Mengjie Xu1, Xu Zhao1, Kaishun Bi2, Ying Jia1.
Abstract
Schisandrin C (SCH-C) is a main and typical antioxidative lignan isolated from the fruits of Schisandra chinensis (Trucz.) Baill (a widely used traditional Chinese medicine). The present study aimed to characterize the effect of SCH-C on memory impairment and further research on pathological changes in Aβ1-42 -induced Alzheimer's disease mice. Mice were administration with SCH-C daily for 5 days in the lateral cerebral ventricles using sterotaxically implanted cannula. Cognitive functions were assessed by Y-maze test, active avoidance test and Morris water maze test in all groups, and the level of Aβ1-42 and neuronal injury induced by Aβ1-42 were reversed remarkably following SCH-C treatment compared with sham group; meanwhile the impairment of short-term or working memory was dramatically improved. In addition, SCH-C significantly inhibited total cholinesterase (ChEtotal), and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) activity glutathione (GSH) levels in the hippocampus and cerebral cortex. It can be speculated that SCH-C offers protection against Aβ1-42 -induced dysfunction in learning and memory by inhibiting ChEtotal and its antioxidant action.Entities:
Keywords: Alzheimer's disease; Aβ1-42; antioxidant; intracerebroventricular injection; neuroprotective effect; schisandrin C
Year: 2015 PMID: 26074330 DOI: 10.1002/ptr.5390
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878